144 related articles for article (PubMed ID: 38092079)
1. Consensus Guidelines for Ocular Surveillance of von Hippel-Lindau Disease.
Daniels AB; Chang EY; Chew EY; Gombos DS; Gorin MB; Shields CL; Wiley HE
Ophthalmology; 2024 May; 131(5):622-633. PubMed ID: 38092079
[TBL] [Abstract][Full Text] [Related]
2. Novel Manifestation of Retinal Hemangioblastomas Detected by OCT Angiography in von Hippel-Lindau Disease.
Takahashi A; Muraoka Y; Koyasu S; Arakawa Y; Nakamura E; Tsujikawa A
Ophthalmology; 2023 Jul; 130(7):748-755. PubMed ID: 36775026
[TBL] [Abstract][Full Text] [Related]
3. VON HIPPEL-LINDAU DISEASE: Update on Pathogenesis and Systemic Aspects.
Aronow ME; Wiley HE; Gaudric A; Krivosic V; Gorin MB; Shields CL; Shields JA; Jonasch EW; Singh AD; Chew EY
Retina; 2019 Dec; 39(12):2243-2253. PubMed ID: 31095066
[TBL] [Abstract][Full Text] [Related]
4. Hemangioblastoma diagnosis and surveillance in von Hippel-Lindau disease: a consensus statement.
Huntoon K; Shepard MJ; Lukas RV; McCutcheon IE; Daniels AB; Asthagiri AR
J Neurosurg; 2022 Jun; 136(6):1511-1516. PubMed ID: 34598132
[TBL] [Abstract][Full Text] [Related]
5. Molecular pathology and CXCR4 expression in surgically excised retinal hemangioblastomas associated with von Hippel-Lindau disease.
Liang X; Shen D; Huang Y; Yin C; Bojanowski CM; Zhuang Z; Chan CC
Ophthalmology; 2007 Jan; 114(1):147-56. PubMed ID: 17070589
[TBL] [Abstract][Full Text] [Related]
6. Longitudinal analysis of retinal hemangioblastomatosis and visual function in ocular von Hippel-Lindau disease.
Toy BC; Agrón E; Nigam D; Chew EY; Wong WT
Ophthalmology; 2012 Dec; 119(12):2622-30. PubMed ID: 22906772
[TBL] [Abstract][Full Text] [Related]
7. MANAGEMENT OF RETINAL HEMANGIOBLASTOMA IN VON HIPPEL-LINDAU DISEASE.
Wiley HE; Krivosic V; Gaudric A; Gorin MB; Shields C; Shields J; Aronow ME; Chew EY
Retina; 2019 Dec; 39(12):2254-2263. PubMed ID: 31259811
[TBL] [Abstract][Full Text] [Related]
8. Retinal hemangioblastoma in von Hippel-Lindau disease: a clinical and molecular study.
Dollfus H; Massin P; Taupin P; Nemeth C; Amara S; Giraud S; Béroud C; Dureau P; Gaudric A; Landais P; Richard S
Invest Ophthalmol Vis Sci; 2002 Sep; 43(9):3067-74. PubMed ID: 12202531
[TBL] [Abstract][Full Text] [Related]
9. Management recommendations for pancreatic manifestations of von Hippel-Lindau disease.
Laks S; van Leeuwaarde R; Patel D; Keutgen XM; Hammel P; Nilubol N; Links TP; Halfdanarson TR; Daniels AB; Tirosh A;
Cancer; 2022 Feb; 128(3):435-446. PubMed ID: 34735022
[TBL] [Abstract][Full Text] [Related]
10. A novel mutation in the VHL gene in a Chinese family with von Hippel-Lindau disease.
Wu X; Chen L; Zhang Y; Xie H; Xue M; Wang Y; Huang H
BMC Med Genet; 2018 Nov; 19(1):204. PubMed ID: 30477447
[TBL] [Abstract][Full Text] [Related]
11. Von Hippel-Lindau disease (vHL). National clinical guideline for diagnosis and surveillance in Denmark. 3rd edition.
Binderup ML; Bisgaard ML; Harbud V; Møller HU; Gimsing S; Friis-Hansen L; Hansen Tv; Bagi P; Knigge U; Kosteljanetz M; Bøgeskov L; Thomsen C; Gerdes AM; Ousager LB; Sunde L;
Dan Med J; 2013 Dec; 60(12):B4763. PubMed ID: 24355456
[TBL] [Abstract][Full Text] [Related]
12. Von hippel-lindau disease: a genetic and clinical review.
Haddad NM; Cavallerano JD; Silva PS
Semin Ophthalmol; 2013; 28(5-6):377-86. PubMed ID: 24138046
[TBL] [Abstract][Full Text] [Related]
13. Deletion of the von Hippel-Lindau Gene in Hemangioblasts Causes Hemangioblastoma-like Lesions in Murine Retina.
Wang H; Shepard MJ; Zhang C; Dong L; Walker D; Guedez L; Park S; Wang Y; Chen S; Pang Y; Zhang Q; Gao C; Wong WT; Wiley H; Pacak K; Chew EY; Zhuang Z; Chan CC
Cancer Res; 2018 Mar; 78(5):1266-1274. PubMed ID: 29301791
[TBL] [Abstract][Full Text] [Related]
14. Clinical characteristics of ocular angiomatosis in von Hippel-Lindau disease and correlation with germline mutation.
Webster AR; Maher ER; Moore AT
Arch Ophthalmol; 1999 Mar; 117(3):371-8. PubMed ID: 10088816
[TBL] [Abstract][Full Text] [Related]
15. Outcome and genetic analysis of patients affected by retinal capillary hemangioblastoma in von Hippel Lindau syndrome.
Murro V; Lippera M; Mucciolo DP; Canu L; Ercolino T; De Filpo G; Giorgio D; Traficante G; Sodi A; Virgili G; Giansanti F
Mol Vis; 2021; 27():542-554. PubMed ID: 34566400
[TBL] [Abstract][Full Text] [Related]
16. Unusual ocular presentation of von Hippel-Lindau disease.
Valenzuela A; Druker H; Malkin D; Gallie B; Héon E
Can J Ophthalmol; 2005 Oct; 40(5):593-7. PubMed ID: 16391622
[TBL] [Abstract][Full Text] [Related]
17. Molecular characterization and ophthalmic investigation of a large family with type 2A Von Hippel-Lindau Disease.
Allen RC; Webster AR; Sui R; Brown J; Taylor CM; Stone EM
Arch Ophthalmol; 2001 Nov; 119(11):1659-65. PubMed ID: 11709017
[TBL] [Abstract][Full Text] [Related]
18. Two pediatric patients with Von Hippel-Lindau disease type 2b: from patient to screening, from screening to patient.
Gonc N; Engiz O; Neumann HP; Demirbilek H; Ozon A; Alikasifoglu A; Kandemir N
J Pediatr Endocrinol Metab; 2011; 24(1-2):109-12. PubMed ID: 21528828
[TBL] [Abstract][Full Text] [Related]
19. Von Hippel-Lindau disease (VHL): a need for a murine model with retinal hemangioblastoma.
Park S; Chan CC
Histol Histopathol; 2012 Aug; 27(8):975-84. PubMed ID: 22763871
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
